Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Demyelinating diseases in Asia.
Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Highly polarized Th17 cells induce EAE via a T-bet-independent mechanism.
Disruption of estrous cycle homeostasis in mice with experimental autoimmune encephalomyelitis.
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Vitamin D Modulates the Expression of IL-27 and IL-33 in the Central Nervous System in Experimental Autoimmune Encephalomyelitis (EAE).
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Deficiency of NF-kappaB c-Rel Accelerates the Development of Autoimmune Diabetes in Non-Obese Diabetic Mice.
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Online CBT in patients with multiple sclerosis and depression.
Neuroprotection of Neuro2a cells and the cytokine suppressive and anti-inflammatory mode of action of resveratrol in activated RAW264.7 macrophages and C8-B4 microglia.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
A systematic review of stress-management interventions for multiple sclerosis patients.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »